The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab

BACKGROUND: To evaluate the association of clinical outcomes with posttreatment changes in the relative eosinophil count (REC) and neutrophil-to-eosinophil ratio (NER) in patients with advanced urothelial cancer (UC) treated with pembrolizumab. MATERIALS AND METHODS: We retrospectively analyzed 105...

Descripción completa

Detalles Bibliográficos
Autores principales: Furubayashi, Nobuki, Minato, Akinori, Negishi, Takahito, Sakamoto, Naotaka, Song, Yoohyun, Hori, Yoshifumi, Tomoda, Toshihisa, Tamura, Shingo, Kuroiwa, Kentaro, Seki, Narihito, Fujimoto, Naohiro, Nakamura, Motonobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554313/
https://www.ncbi.nlm.nih.gov/pubmed/34729023
http://dx.doi.org/10.2147/CMAR.S333823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554313/
https://www.ncbi.nlm.nih.gov/pubmed/34729023
http://dx.doi.org/10.2147/CMAR.S333823

Ejemplares similares